NRXN1 and Pitt-Hopkins syndrome: The marked heterogeneity observed in genotypic and phenotypic manifestations among individuals with NRXN1 deletion symptoms and PTHS highlights the need for further research to understand the similar and different mechanisms of pathophysiology [2,3,14].